| Despite their potential, novel molecules often face long development timelines and require tailored and innovative solutions. In this webinar, experts from Lonza share best practices to boost productivity, fast track your toxicological material's supply and streamline development through integrated DNA-to-IND programs, helping to expedite the path to clinic. Access now for technical case studies showcasing successful drug development projects, and learn how a CDMO with the right expertise can support your continuous progress at every step. | 